Indianapolis, IN, United States of America

Douglas Linn Gernert

This inventor holds 10 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Eli Lilly and Company, Kyowa Hakko Kogyo Co., Ltd., Ligand Pharmaceuticals, Inc.. Active years: 2005-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Douglas Linn Gernert. Retrieved from https://idiyas.com/inventor/douglas-linn-gernert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 3)

% Patents Active = 60.0

CIPO Patents = 2 (Patent Applications = 5)

EPO Patents = 2 (Patent Applications = 7)

Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Indianapolis, IN (US) (2005 - 2016)
Fishers, IN (US) (2024)

Company Filing History:

9 out of 4,509

Eli Lilly and Company

patents

1 out of 730

Kyowa Hakko Kogyo Co., Ltd.

patents

1 out of 139

Ligand Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2005-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735433 - Macrocyclic glucagon-like peptide 1 receptor agonists (2026-09-15),

2. 12723046 - cGAS inhibitors (2026-09-01),

3. 12516063 - Substituted 7-(methylamino)pyrazolo[1,5-a]pyrimidine-3-carboxamide derivatives for treating autoimmune diseases (2026-01-06),

4. 12479822 - AHR agonists (2025-11-25),

5. 12037322 - AHR agonists (2024-07-16),

6. 9469632 - [object Object] (2016-10-18),

7. 7749992 - Compounds and methods for treating dislipidemia (2010-07-06),

8. 7507832 - Triazole PPAR modulators (2009-03-24),

9. 7348359 - Retinoid X receptor modulators (2008-03-25),

10. 6861530 - Piperidine derivatives (2005-03-01),

I specialize in innovations, inventions, inventors, patent attorneys, assignees, and patents.

Profile summary based on public USPTO records.